ChromoTek
Chemicals & Related Products · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
62 Enter Ln 64, Islandia, New York, 1174...Phone Number
(631) 501-1058Website
www.chromotek.comRevenue
$9.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ChromoTek
ChromoTek is a pioneer in the development and commercialization of innovative reagents based on camelid Nanobodies. In contrast to traditional antibodies, Nanobodies consist of only one single polypeptide chain; they are the smallest known antibodies. The company has a unique experience in the development of Nanobodies with desired affinities, specificities, and formats for dedicated applications in biomedical research where other antibody formats fail. As a market and product leader for high performing reagents, we are proud contributing to breakthrough research discoveries around the world. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008, ChromoTek has offices in Martinsried (Germany) near Munich and Islandia (NY, USA).Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ChromoTek your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ChromoTek launches new products
Click to see if ChromoTek had a recent Job posting/layoffs
Check if ChromoTek has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ChromoTek, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ChromoTek has new funding data
Earning: See what the market has to say on ChromoTek recently announced quarterly report
Check out if ChromoTek is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ChromoTek
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ChromoTek
Compare insights from companies similar to ChromoTek, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ChromoTek
$9.9M
11-50
Private
-
2008
N/A
Company Profile Activity
Activity Insights
ChromoTek is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ChromoTek is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ChromoTek.
ChromoTek Tech Stack
A closer look at the technologies used by ChromoTek
See more technologies
ChromoTek News & Media
Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools
CHICAGO & MUNICH--(BUSINESS WIRE)-- #Antibodies--Proteintech, the benchmark in antibodies, announces the acquisition of ChromoTek, a manufacturer of high-performance recombinant reagents, nanobodies.New Partnership Announced Between SciCrunch and ChromoTek
SAN DIEGO, April 27, 2020 /PRNewswire/ -- SciCrunch's Antibody Registry announced this week that it has partnered with ChromoTek to assign unique identifiers (RRIDs) to ChromoTek's line of Nanobody based immunoreagents and antibodies. The partnership increases the database of RRIDs...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ChromoTek
Sign Up For FreeTo access detailed company insights
ChromoTek is a pioneer in the development and commercialization of innovative reagents based on camelid Nanobodies. In contrast to traditional antibodies, Nanobodies consist of only one single polypeptide chain; they are the smallest known antibodies. The company has a unique experience in the development of Nanobodies with desired affinities, spec... Read More
